Obesity and oncological outcome after radical prostatectomy: impact of prostate‐specific antigen‐based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center Databases

To indirectly test the hypothesis that prostate‐specific antigen (PSA)‐based screening is biased against obese men due to haemodilution of PSA, and thus results in delayed diagnosis and poorer outcome beyond the biological link between obesity and aggressive prostate cancer.

[1]  M. Terris,et al.  Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. , 2007, JAMA.

[2]  D. Albanes,et al.  Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality , 2007, Cancer.

[3]  D. Freedman,et al.  Obesity Is Negatively Associated with Prostate-Specific Antigen in U.S. Men, 2001-2004 , 2007, Cancer Epidemiology Biomarkers & Prevention.

[4]  Carmen Rodriguez,et al.  Body Mass Index, Weight Change, and Risk of Prostate Cancer in the Cancer Prevention Study II Nutrition Cohort , 2007, Cancer Epidemiology Biomarkers & Prevention.

[5]  A. Haese*,et al.  Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy. , 2007, European journal of cancer.

[6]  C. Matthews,et al.  Effects of obesity and height on prostate‐specific antigen (PSA) and percentage of free PSA levels among African‐American and Caucasian men , 2006, Cancer.

[7]  A. Partin,et al.  Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality. , 2006, The Journal of urology.

[8]  K. Do,et al.  Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  M. Cooperberg,et al.  Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. , 2005, Urology.

[10]  A. Partin,et al.  Obesity and capsular incision at the time of open retropubic radical prostatectomy. , 2005, The Journal of urology.

[11]  P. Walsh.  The association of body mass index and prostate-specific antigen in a population-based study. , 2005, The Journal of urology.

[12]  A. Partin,et al.  Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center. , 2005, The Journal of urology.

[13]  M. Kattan,et al.  Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy , 2005, Cancer.

[14]  A. Partin,et al.  Stronger Association between Obesity and Biochemical Progression after Radical Prostatectomy among Men Treated in the Last 10 Years , 2005, Clinical Cancer Research.

[15]  E. Crawford,et al.  Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening program. , 2005, Urology.

[16]  M. Terris,et al.  Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Timothy F. Donahue,et al.  Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  M. Terris,et al.  Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database. , 2003, The Journal of urology.

[19]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[20]  M. Thun,et al.  Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.